HOUT-28. CLINICAL EXPERIENCE WITH TUMOR TREATING FIELDS (TTFIELDS, OPTUNE®) IN ISRAEL - PATIENT ACCEPTANCE AND SAFETY

BACKGROUND: TTFields are low intensity, intermediate frequency alternating electric fields, delivered through a portable, non-invasive device (Optune, Novocure(TM)). The EF-14 phase III trial showed significant prolongation of both progression-free and overall survival in newly diagnosed glioblastom...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Siegal, Tali, Bokstein, Felix, Blumenthal, Deborah T, Zach, Leor, Leibovici, Anca, Yust-Katz, Shlomit, Lossos, Alexander, Tzuk-Shina, Tzahala, Lokiec, Alejandro, Grossman, Rachel, Forschner, Itay, Taliansky, Alisa, Ram, Zvi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217270/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.496
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg